Titan Health Partners Llc

CLIA Laboratory Citation Details

4
Total Citations
10
Total Deficiencyies
9
Unique D-Tags
CMS Certification Number 31D2041037
Address One Exchange Place, Jersey City, NJ, 07302
City Jersey City
State NJ
Zip Code07302
Phone732 390-7750
Lab DirectorAMIT PATEL

Citation History (4 surveys)

Survey - February 25, 2025

Survey Type: Standard

Survey Event ID: LPPO11

Deficiency Tags: D5801

Summary:

Summary Statement of Deficiencies D5801 TEST REPORT CFR(s): 493.1291(a) (a) The laboratory must have an adequate manual or electronic system(s) in place to ensure test results and other patient-specific data are accurately and reliably sent from the point of data entry (whether interfaced or entered manually) to final report destination, in a timely manner. This includes the following: (a)(1) Results reported from calculated data. (a)(2) Results and patient-specific data electronically reported to network or interfaced systems. (a)(3) Manually transcribed or electronically transmitted results and patient-specific information reported directly or upon receipt from outside referral laboratories, satellite or point-of-care testing locations. This STANDARD is not met as evidenced by: Based on surveyor review of the Final Report (FR) Work Records (WR), Electronic Medical Records (EMR) and interview with the Laboratory Coordinator (LC) the laboratory failed to ensure test results were reported accurately for Compete Blood Count (CBC) testing into the EMR on 2/25/25. The finding includes: 1. A review of five EMR entries revealed one patient had results as follows: a) White Blood Cell (WBC) on the WR was 10.6 10^3/mm^3 but the FR had 7.7 10^3/mm^3 b) Red Blood Cell Count (RBC) on the WR was 4.49 10^6/mm^6 but the FR had 4.48 10^6 /mm^6 c) Hemoglobin (Hgb) on the WR was 12.8 g/dL but the FR had 12.4 g/dL d) Hematocrit (HCT) on the WR was 38.5 % but the FR had 37.9 % e) Platelets (PLT) on the WR was 133 10^3/mm^3 but the FR had 155 10^3/mm^3 2. The LC confirmed on 2/25/25 at 1:30 pm that the laboratory did not ensure test results were accurately recorded in the EMR. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 17, 2023

Survey Type: Standard

Survey Event ID: 61ML11

Deficiency Tags: D2007 D6070

Summary:

Summary Statement of Deficiencies D2007 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The samples must be examined or tested with the laboratory's regular patient workload by personnel who routinely perform the testing in the laboratory, using the laboratory's routine methods This STANDARD is not met as evidenced by: Based on surveyor review of the Proficiency Testing (PT), interview with Technical Consultant (TC), the laboratory failed to ensure that all TP who routinely perform Hematology testing participated in the American Proficiency Institute (API) PT in the calendar year 2022 and the 1st and 2nd events of 2023. The findings include: 1. A review of PT attestation records showed that 1 out of 5 TP performed PT in the aforementioned time frame. 2. The TC confirmed on 10/17/23 at 11:30 am that PT events were not rotated between TP. D6070 TESTING PERSONNEL RESPONSIBILITIES CFR(s): 493.1425(b)(1) Each individual performing moderate complexity testing must follow the laboratory's procedures for specimen handling and processing, test analyses, reporting and maintaining records of patient test results. This STANDARD is not met as evidenced by: Based on surveyor observation of Test Reports (TR), Procedure Manual (PM) and interview with the Technical Consultant (TC), Testing Personnel (TP) failed to follow procedures for Hematology test analyses performed on the Horiba Micros 60 analyzer. The findings include: 1. The PM states "Indication 5. $ analyzed the parameter for max 3 counts. Suggested action 5. Invert tube and rerun. Otherwise send out to Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- reference lab." 2. Two Patients TR Identification numbers 24499 and 25211 had "$" flagged results for: a. White Blood Cell (WBC) b. % Lymphocyte (LYM) c. % Monocyte (MON) d. % Granulocyte (GRA) e. #LYM f. #MON g. #GRA 3. There was no documented evidence that the TP followed the PM as mentioned above. 4. The TC confirmed on 10/17/19 at 12:00 pm that the TP failed to follow laboratory procedures for test analyses. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 14, 2021

Survey Type: Standard

Survey Event ID: DNLZ11

Deficiency Tags: D5807

Summary:

Summary Statement of Deficiencies D5807 TEST REPORT CFR(s): 493.1291(d) Pertinent "reference intervals" or "normal" values, as determined by the laboratory performing the tests, must be available to the authorized person who ordered the tests and, if applicable, the individual responsible for using the test results. This STANDARD is not met as evidenced by: Based on surveyor review of the Final Report (FR) and interview with the Testing Personnel (TP), the laboratory failed to ensure that the Normal Reference Intervals (NRI) were indicated on the FR for Hematology from July 2018 to the date of survey. The TP confirmed on 10/14/21 at 11:35 am that the NRI were not on the FR. Note: This was preiously cited 9/12/18 Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 12, 2018

Survey Type: Standard

Survey Event ID: 4QUW11

Deficiency Tags: D5221 D5421 D5807 D5891 D6013 D6030

Summary:

Summary Statement of Deficiencies D5221 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(d) All proficiency testing evaluation and verification activities must be documented. This STANDARD is not met as evidenced by: Based on surveyor review of the Proficiency Testing (PT) records and interview with the Testing Personnel (TP), the laboratory failed to evaluate results when they received an unacceptable score in Hematology performed with the American Proficiency Institute (API) in the 1st and 2nd events of 2018. The findings include: 1. There was no review or evaluation documented when the laboratory received an unacceptable grade for White Blood Cell sample COU - 02 in 1-2018 and Monocyte % sample COU - 07 in 2-2018. 2. There was no documented evidence the laboratory investigated the failures. 3. The TP confirmed on 9/12/18 at 10:20 am that the laboratory did not perform and document an evaluation of unacceptable PT results. D5421 ESTABLISHMENT AND VERIFICATION OF PERFORMANCE CFR(s): 493.1253(b)(1) Each laboratory that introduces an unmodified, FDA-cleared or approved test system must do the following before reporting patient test results: (1)(i) Demonstrate that it can obtain performance specifications comparable to those established by the manufacturer for the following performance characteristics: (1)(i)(A) Accuracy. (1)(i) (B) Precision. (1)(i)(C) Reportable range of test results for the test system. (1)(ii) Verify that the manufacturer's reference intervals (normal values) are appropriate for the laboratory's patient population. This STANDARD is not met as evidenced by: Based on surveyor review of Performance Specifications (PS) records and interview Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- with the Testing Personnel (TP), the laboratory failed to verify Precision and Reportable Range for all Hematology analytes performed on the Beckman Coulter Unicel DX 600 analyzer before reporting patient test results from January 2018 to the date of survey. The TP confirmed on 9/12/18 at 11:40 am that all PS were not done. D5807 TEST REPORT CFR(s): 493.1291(d) Pertinent "reference intervals" or "normal" values, as determined by the laboratory performing the tests, must be available to the authorized person who ordered the tests and, if applicable, the individual responsible for using the test results. This STANDARD is not met as evidenced by: Based on surveyor review of the Final Report (FR) and interview with the Testing Personnel (TP), the laboratory failed to ensure that the Normal Reference Intervals (NRI) were indicated on the FR for Hematology from July 2018 to the date of survey. The TP confirmed on 9/12/18 at 11:35 am that the NRI were not on the FR. D5891 POSTANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1299(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess and, when indicated, correct problems identified in the postanalytic systems specified in 493.1291. This STANDARD is not met as evidenced by: a. Based on surveyor review of the Final Report (FR), Reference Intervals (RI) found in the Procedure Manual (PM) and interview with the Testing Personnel (TP), the laboratory failed to correct problems in the postanalytic system when the test results were flagged as a abnormal from 9/15/16 to the date of the survey. The findings include: 1. The FR revealed that results were flagged as abnormal (AB) but were within the RI as below: a. Monocyte Number : 0.2 AB - RI 0.1 - 0.6 b. Monocyte Percent: 2.7 AB - RI 1.7 - 9.3 c. Granulocyte Percent: 67.6 AB - RI 42.2 - 75.6 d. Absolute Neutrophil Count: 5.2 Abnormal - RI 1.4 - 6.5 2. The TP confirmed on 9/12 /18 at 11:10 am that AB flagging was incorrect on the FR. b. Based on surveyor review of the FR, Units of Measure (UM) found in the PM and interview with the TP, the laboratory failed to correct problems in the postanalytic system when the UM were not accurate on the FR in the calendar year 2018. The findings include: 1. The UM were reported as 10 for: Basophil Number (#), Eosinophil #, Neutrophil #, Lymphocyte #, White Blood Cells (WBC), UWBC, Red Blood Cells and Platelets. 2. The TP confirmed on 9/12/18 at 11:40 am that UM were incorrect on the FR. D6013 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(3)(ii) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(3) Ensure that-- (e)(3)(ii) Verification procedures used are adequate to determine the accuracy, precision, and other pertinent performance -- 2 of 3 -- characteristics of the method; This STANDARD is not met as evidenced by: Based on surveyor review of the Performance Specification (PS) records and interview with the Testing Personnel (TP), the Laboratory Director (LD) failed to ensure that PS procedures performed on the Beckman Coulter Unicel DXH 600 analyzer were adequate from January 2018 to the date of survey. The findings include: 1. The LD did not review and sign the Method Comparison (MC) results. 2. There was no documented criteria for acceptance of the MC. 3. The LD confirmed on 9/12 /18 at 11:15 am that PS records were not adequate. D6030 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(12) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(12) Ensure that policies and procedures are established for monitoring individuals who conduct preanalytical, analytical, and postanalytical phases of testing to assure that they are competent and maintain their competency to process specimens, perform test procedures and report test results promptly and proficiently, and whenever necessary, identify needs for remedial training or continuing education to improve skills; This STANDARD is not met as evidenced by: Based on surveyor review of the Procedure Manual and interview with the Testing Personnel (TP), the Laboratory Director failed to establish a Competency Assessment (CA) procedure with the required elements from 9/15/16 to the date of the survey. The TP confirmed on 9/12/18 at 10:00 am that a CA procedure was not established. -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access